Andrei Paul Negru (Paul Andrei Negru)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Ejection Fraction

Molecular Docking

Interstitial Lung Disease

Ankylosing Spondylitis

Top Venues

Molecules (Basel, Switzerland)

Bioengineering (Basel, Switzerland)

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Andrei-Flavius Radu, Simona Gabriela Bungau, Andrei Paul Negru, Bogdan Uivaraseanu, Mihaela Alexandra Bogdan
Novel Potential Janus Kinase Inhibitors with Therapeutic Prospects in Rheumatoid Arthritis Addressed by In Silico Studies. Molecules (Basel, Switzerland) 28 (12) (2023)
Andrei-Flavius Radu, Simona Gabriela Bungau, Andrei Paul Negru, Bogdan Uivaraseanu, Mihaela Alexandra Bogdan
Novel Potential Janus Kinase Inhibitors with Therapeutic Prospects in Rheumatoid Arthritis Addressed by In Silico Studies. Molecules (Basel, Switzerland) 28 (12) (2023)
Andrei-Flavius Radu, Andrei Paul Negru, Ada Radu, Alexandra Georgiana Tarce, Simona Gabriela Bungau, Mihaela Alexandra Bogdan, Delia Mirela Ţiț, Bogdan Uivaraseanu
Simulation-Based Research on Phytoconstituents of Embelia ribes Targeting Proteins with Pathophysiological Implications in Rheumatoid Arthritis. Life (Basel, Switzerland) 13 (7) (2023)
Flaviu Bodea, Simona Gabriela Bungau, Andrei Paul Negru, Ada Radu, Alexandra Georgiana Tarce, Delia Mirela Ţiț, Alexa Florina Bungau, Cristian Bustea, Tapan Behl, Andrei-Flavius Radu
Exploring New Therapeutic Avenues for Ophthalmic Disorders: Glaucoma-Related Molecular Docking Evaluation and Bibliometric Analysis for Improved Management of Ocular Diseases. Bioengineering (Basel, Switzerland) 10 (8) (2023)
Andrei-Flavius Radu, Simona Gabriela Bungau, Andrei Paul Negru, Bogdan Uivaraseanu, Mihaela Alexandra Bogdan
Novel Potential Janus Kinase Inhibitors with Therapeutic Prospects in Rheumatoid Arthritis Addressed by In Silico Studies. Molecules (Basel, Switzerland) 28 (12) (2023)